Suppr超能文献

以用户为中心的临床决策支持对儿科血制品医嘱错误的影响。

Influence of user-centered clinical decision support on pediatric blood product ordering errors.

机构信息

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America.

Division of Hospital Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States of America.

出版信息

Blood Transfus. 2023 Jan;21(1):3-12. doi: 10.2450/2022.0309-21. Epub 2022 May 10.

Abstract

BACKGROUND

Children are at increased risk from transfusion-related medical errors. Clinical decision support (CDS) can enhance pediatric providers' decision-making regarding transfusion practices including indications, volume, rate, and special processing instructions. Our objective was to use CDS in a pediatric health system to reduce:blood product-related safety events from ordering errors;special processing ordering errors for patients with T-cell dysfunction, sickle cell disease (SCD), or thalassemia;transfusions administered faster than 5 mL/kg/h.

MATERIALS AND METHODS

In this single-center before and after quality improvement study, we evaluated how user-centered design of pediatric blood product orders influenced pediatric transfusion practices and outcomes. Safety events were identified through active and passive surveillance. Other clinically relevant outcomes were identified through electronic health record queries.

RESULTS

Blood product-related safety events from ordering errors did not change significantly from the baseline period (6 events, 0.4 per month, from 1/1/2018-3/27/2019) to the intervention period (1 event, 0.1 per month, from 3/28/2019-12/31/2019; rate ratio: 0.27 [0.01-2.25]). Packed red blood cell (PRBC) and platelet orders for patients with T-cell dysfunction that did not specify irradiation decreased significantly from 488/12,359 (3.9%) to 204/6,711 (3.0%, risk ratio: 0.77 [0.66-0.90]). PRBC orders for patients with SCD or thalassemia that did not specify phenotypically similar units fell from 386/2,876 (13.4%) to 57/1,755 (3.2%, risk ratio: 0.24 [0.18-0.32]). Transfusions administered faster than 5 mL/kg/h decreased from 4,112/14,641 (28.1%) to 2,125/9,263 (22.9%, risk ratio: 0.82 [0.78-0.85]).

DISCUSSION

User-centered design of CDS for pediatric blood product orders significantly reduced special processing ordering errors and inappropriate transfusion rates. Larger studies are needed to evaluate the impact on safety events.

摘要

背景

儿童在输血相关医疗错误方面的风险增加。临床决策支持(CDS)可以增强儿科医务人员在输血实践方面的决策能力,包括适应证、容量、速度和特殊处理说明。我们的目标是在儿科医疗系统中使用 CDS 减少:因医嘱错误导致的与血液制品相关的安全事件;T 细胞功能障碍、镰状细胞病(SCD)或地中海贫血患者的特殊处理医嘱错误;输血速度超过 5mL/kg/h。

材料和方法

在这项单中心的前后质量改进研究中,我们评估了以患儿为中心的血液制品医嘱设计如何影响儿科输血实践和结果。通过主动和被动监测来识别安全事件。通过电子健康记录查询来识别其他临床相关结果。

结果

从医嘱错误引起的与血液制品相关的安全事件在基线期(6 起事件,0.4 起/月,1/1/2018-3/27/2019)和干预期(1 起事件,0.1 起/月,3/28/2019-12/31/2019)均无显著变化;速率比为 0.27(0.01-2.25)。T 细胞功能障碍患儿的浓缩红细胞(PRBC)和血小板医嘱未注明照射的比例从 488/12359(3.9%)显著下降至 204/6711(3.0%),风险比为 0.77(0.66-0.90)。SCD 或地中海贫血患儿的 PRBC 医嘱未注明表型相似单位的比例从 386/2876(13.4%)下降至 57/1755(3.2%),风险比为 0.24(0.18-0.32)。输血速度超过 5mL/kg/h 的比例从 4112/14641(28.1%)下降至 2125/9263(22.9%),风险比为 0.82(0.78-0.85)。

讨论

以患儿为中心的 CDS 设计用于儿科血液制品医嘱显著减少了特殊处理医嘱错误和不适当的输血率。需要更大规模的研究来评估对安全事件的影响。

相似文献

10
Alloimmunization in transfused patients with constitutional anemias in Norway.挪威患有先天性贫血的输血患者中的同种免疫
Transfus Apher Sci. 2021 Oct;60(5):103257. doi: 10.1016/j.transci.2021.103257. Epub 2021 Aug 17.

本文引用的文献

5
Safety incident reports associated with blood transfusions.输血相关安全事件报告。
Transfusion. 2019 Sep;59(9):2827-2832. doi: 10.1111/trf.15429. Epub 2019 Jun 29.
6
Clinical Decision Support for Pediatric Blood Product Prescriptions.儿科血液制品处方的临床决策支持
J Pediatr Intensive Care. 2016 Sep;5(3):108-112. doi: 10.1055/s-0035-1569996. Epub 2015 Dec 15.
9
Guidelines on transfusion for fetuses, neonates and older children.胎儿、新生儿及大龄儿童输血指南。
Br J Haematol. 2016 Dec;175(5):784-828. doi: 10.1111/bjh.14233. Epub 2016 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验